thy1 Search Results


94
R&D Systems allophycocyanin apc conjugated anti cd90 thy1
Allophycocyanin Apc Conjugated Anti Cd90 Thy1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/allophycocyanin apc conjugated anti cd90 thy1/product/R&D Systems
Average 94 stars, based on 1 article reviews
allophycocyanin apc conjugated anti cd90 thy1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

91
Novus Biologicals cd90
Cd90, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd90/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
cd90 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

93
R&D Systems anti human cd90 conjugated to pe
Anti Human Cd90 Conjugated To Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd90 conjugated to pe/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti human cd90 conjugated to pe - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Addgene inc thy1 2 promoter construct
Thy1 2 Promoter Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thy1 2 promoter construct/product/Addgene inc
Average 93 stars, based on 1 article reviews
thy1 2 promoter construct - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Addgene inc rack1
Fig. 4 | AIM2 promotes Treg cells in vitro and restrains AKT–mTOR via the <t>RACK1–PP2A</t> complex. a, b, RT–PCR (a) and flow cytometry (b) of FOXP3 in wild-type and Aim2−/− CD4+ T cells activated with the indicated amounts (a) or 2 ng ml−1 (b) of TGFβ for 4 days; n = 5 experiments in a and n = 4 experiments in b. c, Flow cytometry of IFNγ+ or IL-17A+ CD4+ T cells of indicated genotypes, 4 days after differentiation under indicated polarizing conditions; n = 4 experiments. cTH17, classic TH17; pTH17, pathogenic TH17. d–g, Wild-type and Aim2−/− CD4+ T cells were stimulated as in b. d, Enrichment scores of indicated gene sets, based on RNA-seq datasets. e, f, ECAR (e) and OCR (f) levels during glycolysis, and OCR levels during fatty acid oxidation (g), by Seahorse analysis; n = 10 experiments for e; n = 5 experiments for f; and n = 3 experiments for g. h, Immunoblotting of indicated proteins in wild-type and Aim2−/− CD4+ T cells stimulated as in b with indicated treatment for 24 h. Representative of three
Rack1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rack1/product/Addgene inc
Average 93 stars, based on 1 article reviews
rack1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
Bio X Cell invivomab anti mouse cd90 2 thy1 2
Fig. 4 | AIM2 promotes Treg cells in vitro and restrains AKT–mTOR via the <t>RACK1–PP2A</t> complex. a, b, RT–PCR (a) and flow cytometry (b) of FOXP3 in wild-type and Aim2−/− CD4+ T cells activated with the indicated amounts (a) or 2 ng ml−1 (b) of TGFβ for 4 days; n = 5 experiments in a and n = 4 experiments in b. c, Flow cytometry of IFNγ+ or IL-17A+ CD4+ T cells of indicated genotypes, 4 days after differentiation under indicated polarizing conditions; n = 4 experiments. cTH17, classic TH17; pTH17, pathogenic TH17. d–g, Wild-type and Aim2−/− CD4+ T cells were stimulated as in b. d, Enrichment scores of indicated gene sets, based on RNA-seq datasets. e, f, ECAR (e) and OCR (f) levels during glycolysis, and OCR levels during fatty acid oxidation (g), by Seahorse analysis; n = 10 experiments for e; n = 5 experiments for f; and n = 3 experiments for g. h, Immunoblotting of indicated proteins in wild-type and Aim2−/− CD4+ T cells stimulated as in b with indicated treatment for 24 h. Representative of three
Invivomab Anti Mouse Cd90 2 Thy1 2, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/invivomab anti mouse cd90 2 thy1 2/product/Bio X Cell
Average 95 stars, based on 1 article reviews
invivomab anti mouse cd90 2 thy1 2 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Bio X Cell be0214

Be0214, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/be0214/product/Bio X Cell
Average 93 stars, based on 1 article reviews
be0214 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology antibody against thy1 1

Antibody Against Thy1 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against thy1 1/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
antibody against thy1 1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

92
Novus Biologicals anti mouse rat cd90

Anti Mouse Rat Cd90, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse rat cd90/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
anti mouse rat cd90 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
Cedarlane cl005ap

Cl005ap, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cl005ap/product/Cedarlane
Average 93 stars, based on 1 article reviews
cl005ap - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

96
Elabscience Biotechnology cd90
Identification of rat bone marrow mesenchymal stem cells in vitro . CD45 and <t>CD90</t> were labelled with Cy3 (red) and the cells were stained with DAPI (blue). The results were observed by fluorescence microscopy. (A) CD90 labelled with Cy3 fluorescence; (B) DAPI staining; (C) merged CD90 and DAPI staining. The positive rate of CD90 was >90%. (D) CD45 labelled with Cy3; (E) DAPI staining; (F) merged CD45 and DAPI staining. The positive rate of CD45 was <5%.
Cd90, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd90/product/Elabscience Biotechnology
Average 96 stars, based on 1 article reviews
cd90 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

93
R&D Systems anti cd90
Identification of rat bone marrow mesenchymal stem cells in vitro . CD45 and <t>CD90</t> were labelled with Cy3 (red) and the cells were stained with DAPI (blue). The results were observed by fluorescence microscopy. (A) CD90 labelled with Cy3 fluorescence; (B) DAPI staining; (C) merged CD90 and DAPI staining. The positive rate of CD90 was >90%. (D) CD45 labelled with Cy3; (E) DAPI staining; (F) merged CD45 and DAPI staining. The positive rate of CD45 was <5%.
Anti Cd90, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd90/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti cd90 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 4 | AIM2 promotes Treg cells in vitro and restrains AKT–mTOR via the RACK1–PP2A complex. a, b, RT–PCR (a) and flow cytometry (b) of FOXP3 in wild-type and Aim2−/− CD4+ T cells activated with the indicated amounts (a) or 2 ng ml−1 (b) of TGFβ for 4 days; n = 5 experiments in a and n = 4 experiments in b. c, Flow cytometry of IFNγ+ or IL-17A+ CD4+ T cells of indicated genotypes, 4 days after differentiation under indicated polarizing conditions; n = 4 experiments. cTH17, classic TH17; pTH17, pathogenic TH17. d–g, Wild-type and Aim2−/− CD4+ T cells were stimulated as in b. d, Enrichment scores of indicated gene sets, based on RNA-seq datasets. e, f, ECAR (e) and OCR (f) levels during glycolysis, and OCR levels during fatty acid oxidation (g), by Seahorse analysis; n = 10 experiments for e; n = 5 experiments for f; and n = 3 experiments for g. h, Immunoblotting of indicated proteins in wild-type and Aim2−/− CD4+ T cells stimulated as in b with indicated treatment for 24 h. Representative of three

Journal: Nature

Article Title: AIM2 in regulatory T cells restrains autoimmune diseases.

doi: 10.1038/s41586-021-03231-w

Figure Lengend Snippet: Fig. 4 | AIM2 promotes Treg cells in vitro and restrains AKT–mTOR via the RACK1–PP2A complex. a, b, RT–PCR (a) and flow cytometry (b) of FOXP3 in wild-type and Aim2−/− CD4+ T cells activated with the indicated amounts (a) or 2 ng ml−1 (b) of TGFβ for 4 days; n = 5 experiments in a and n = 4 experiments in b. c, Flow cytometry of IFNγ+ or IL-17A+ CD4+ T cells of indicated genotypes, 4 days after differentiation under indicated polarizing conditions; n = 4 experiments. cTH17, classic TH17; pTH17, pathogenic TH17. d–g, Wild-type and Aim2−/− CD4+ T cells were stimulated as in b. d, Enrichment scores of indicated gene sets, based on RNA-seq datasets. e, f, ECAR (e) and OCR (f) levels during glycolysis, and OCR levels during fatty acid oxidation (g), by Seahorse analysis; n = 10 experiments for e; n = 5 experiments for f; and n = 3 experiments for g. h, Immunoblotting of indicated proteins in wild-type and Aim2−/− CD4+ T cells stimulated as in b with indicated treatment for 24 h. Representative of three

Article Snippet: Ectopic expression of PP2A and RACK1 in Treg cells To generate the retrovirus expressing PP2A and RACK1, we first cloned PP2A (OriGene Technologies, MR204384L4) and RACK1 (OriGene Technologies, MR204575L3) into retroviral vectors MSCV-IRES-Thy1.1 (MIT, Addgene 17442) and MSCV-IRES-GFP (MIG, Addgene 20672) respectively, and generated MIT-PP2A and MIG-RACK1 retrovirus in 293T cells by transient transfection.

Techniques: In Vitro, Reverse Transcription Polymerase Chain Reaction, Flow Cytometry, RNA Sequencing, Western Blot

Journal: eLife

Article Title: Natural Tr1-like cells do not confer long-term tolerogenic memory

doi: 10.7554/eLife.44821

Figure Lengend Snippet:

Article Snippet: Antibody , InVivoMAb mouse monoclonal anti-mouse Thy1.1/CD90.1 (clone 19E12) , BioXcell , Cat: BE0214 , 200 ug/mouse.

Techniques: Flow Cytometry

Identification of rat bone marrow mesenchymal stem cells in vitro . CD45 and CD90 were labelled with Cy3 (red) and the cells were stained with DAPI (blue). The results were observed by fluorescence microscopy. (A) CD90 labelled with Cy3 fluorescence; (B) DAPI staining; (C) merged CD90 and DAPI staining. The positive rate of CD90 was >90%. (D) CD45 labelled with Cy3; (E) DAPI staining; (F) merged CD45 and DAPI staining. The positive rate of CD45 was <5%.

Journal: Experimental and Therapeutic Medicine

Article Title: Effect of Src tyrosine kinase on a rat model of asthma

doi: 10.3892/etm.2021.11095

Figure Lengend Snippet: Identification of rat bone marrow mesenchymal stem cells in vitro . CD45 and CD90 were labelled with Cy3 (red) and the cells were stained with DAPI (blue). The results were observed by fluorescence microscopy. (A) CD90 labelled with Cy3 fluorescence; (B) DAPI staining; (C) merged CD90 and DAPI staining. The positive rate of CD90 was >90%. (D) CD45 labelled with Cy3; (E) DAPI staining; (F) merged CD45 and DAPI staining. The positive rate of CD45 was <5%.

Article Snippet: Concentrated goat serum and Cy3-labeled Goat Anti-Rabbit IgG (cat. no. BA1034) were purchased from Wuhan Boster Biological Technology Co., Ltd.; Entranster TM - in vivo (cat. no. 18668-11-1) was purchased from Engreen Biosystem, Ltd.; Lipofectamine ® 2000 was purchased from Invitrogen (Thermo Fisher Scientific, Inc.); DNA marker was purchased from TransGen Biotech Co., Ltd.; RNAiso Plus, PrimeScript RT Reagent kit and SYBR Premix Ex Taq TM II (Tli RNaseH Plus) were purchased from Takara Bio, Inc.; IL-5 (cat. no. E-EL-R0558c; Elabscience Biotechnology, Inc.), IL-33 (cat. no. CSB-E14077r; Cusabio Technology LLC) and IFN-γ (cat. no. CSB-E04579r; Cusabio Technology LLC) ELISA kits, and CD90 (cat. no. E-AB-70323) and CD45 (cat. no. E-AB-16319) antibodies were purchased from Elabscience Biotechnology, Inc.

Techniques: In Vitro, Staining, Fluorescence, Microscopy